Primary malignant pericardial tumour in Lynch syndrome

Research output: Contribution to journalArticlepeer-review


BACKGROUND: This case represents the first report of malignant primary cardiac tumour in a patient with Lynch Syndrome associated with MSH2 pathogenic variant.

CASE PRESENTATION: A 57-year-old woman with previous ovarian cystadenocarcinoma was admitted to the emergency room for hematic pericardial effusion. Multimodal diagnostic imaging revealed two solid pericardial vascularized masses. After pericardiectomy, the final histological diagnosis was poorly differentiated pleomorphic sarcomatoid carcinoma. During follow-up she developed an ampulla of Vater adenocarcinoma. Genetic analysis identified an MSH2 pathogenic variant.

CONCLUSION: This case contributes to expand the tumour spectrum of Lynch syndrome, suggesting that MSH2 pathogenic variants cause a more complex multi-tumour cancer syndrome than the classic Lynch Syndrome. In MSH2 variant carriers, symptoms such as dyspnoea and chest discomfort might alert for rare tumours and a focused cardiac evaluation should be considered.

Original languageEnglish
Pages (from-to)191
JournalBMC Cancer
Issue number1
Publication statusPublished - Mar 6 2020


  • Adenocarcinoma/complications
  • Ampulla of Vater/pathology
  • Carcinoma/complications
  • Colorectal Neoplasms, Hereditary Nonpolyposis/complications
  • Female
  • Follow-Up Studies
  • Germ-Line Mutation
  • Heart Neoplasms/complications
  • Humans
  • Middle Aged
  • MutS Homolog 2 Protein/genetics
  • Pedigree
  • Pericardial Effusion/complications
  • Pericardiectomy
  • Pericardium/pathology
  • Treatment Outcome


Dive into the research topics of 'Primary malignant pericardial tumour in Lynch syndrome'. Together they form a unique fingerprint.

Cite this